Covid-19 Vaccine: Trump to appoint GlaxoSmithKline executive, US general to lead effort

The United States President, Donald Trump, has disclosed plan to appoint a former GlaxoSmithKline executive and a U.S. general to lead the government’s effort at developing a coronavirus vaccine.

While disclosing this on Wednesday May 13, an administration official said that the effort was an accelerated schedule which is officially described as “Operation Warp Speed”.

The former head of Glaxo’s vaccines division, Moncef Slaoui, will serve as chief adviser on the operation and U.S. General Gustav Perna will act as its chief operating officer.

Trump previously said he would be the top boss on the effort to develop, test and produce on a shortened timeline a vaccine against the deadly coronavirus that has caused a global pandemic.

Whereas, the White House has set a target of having 300 million vaccine doses by the end of 2020.